LP29104-4
Quinupristin+Dalfopristin
Active
Description
These are two chemically unrelated compounds from the streptogramin family that act synergistically. Used to treat vancomycin resistant enterococcus (VRE) due to E. faecium (NOT E. faecalis), and methicillin resistant staph aureus (MRSA). The Quinupristin / Dalfopristin combination inhibits protein synthesis by interfering with different targets on the rRNA 23S in the 50S ribosomal subunit. The synergy appears to be based on ribosomal conformational changes triggered by the binding of the streptogramin A (Dalfopristin), which can cause irreversible attachment of the streptogramin B (Quinupristin) to the ribosome. Source: Regenstrief Institute
Basic Part Properties
- Part Display Name
- Quinupristin+Dalfopristin
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2002-06-18
- Construct for LOINC Short Name
- Quinupristin+Dalfoprist
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP29104-4
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
zh-CN | Chinese (China) | 奎奴普丁+达福普汀 |
fr-CA | French (Canada) | Quinupristine+Dalfopristine |
et-EE | Estonian (Estonia) | Kinupristiin + dalfopristiin |
es-ES | Spanish (Spain) | Quinupristina+Dalfopristina |
it-IT | Italian (Italy) | Quinupristina+Dalfopristina |
tr-TR | Turkish (Turkey) | Kuinupristin+Dalfopristin |
ru-RU | Russian (Russian Federation) | Квинупристин+Дальфопристин |
nl-NL | Dutch (Netherlands) | quinupristine + dalfopristine |
fr-BE | French (Belgium) | Quinupristine+Dalfopristine |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright